ciprofloxacin and pyrvinium

ciprofloxacin has been researched along with pyrvinium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chandal, N; Mahey, N; Nandanwar, H; Tambat, R; Thakur, KG; Verma, DK	1

Other Studies

1 other study(ies) available for ciprofloxacin and pyrvinium

Article	Year
Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus. Microbiology spectrum, 2021, 12-22, Volume: 9, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Pyrvinium Compounds; Raloxifene Hydrochloride; Staphylococcal Infections; Staphylococcus aureus	2021

Article

Year

Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus.

Microbiology spectrum, 2021, 12-22, Volume: 9, Issue:3

Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carrier Proteins; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Multidrug Resistance-Associated Proteins; Norfloxacin; Pyrvinium Compounds; Raloxifene Hydrochloride; Staphylococcal Infections; Staphylococcus aureus

2021